Negative association between circulating total homocysteine and proinflammatory chemokines MCP-1 and RANTES in prepubertal lean, but not in obese, children

Journal of Cardiovascular Pharmacology

Volumn 44, Issue 3, 2004, Pages 310-315

  Economou, Emanuel V ^a   Malamitsi Puchner, Ariadne V ^a   Pitsavos, Christos P ^b   Kouskouni, Evangelia E ^a   Magaziotou Elefsinioti, Ioanna ^c   Damianaki Uranou, Despina ^c   Stefanadis, Christodoulos I ^b   Creatsas, Georgios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Atherosclerosis; Homocysteine; MCP 1; Prepubertal obesity; RANTES

Indexed keywords

CHEMOKINE; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TRIACYLGLYCEROL;

AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; LEAN BODY WEIGHT; LEUKOCYTE MIGRATION; MAJOR CLINICAL STUDY; MALE; OBESITY; PREPUBERTY; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TRIACYLGLYCEROL BLOOD LEVEL;

ARTERIOSCLEROSIS; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; CHILD; CHOLESTEROL, HDL; DATA INTERPRETATION, STATISTICAL; ENDOTHELIUM, VASCULAR; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; INSULIN; MALE; OBESITY; PUBERTY; RANTES; SEX; THINNESS; TRIGLYCERIDES; VITAMIN B 12;

EID: 4344697364     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000133587.01718.59     Document Type: Article

References (34)

1. Must A, Jacques PF, Dallal GE, et al.: Long-term morbidity and mortality of overweight adolescents: A follow-up of the Harvard Growth Study of 1922-1935. N Engl J Med. 1992;327:1350-1355.
2. Selhub J, Jacques PF, Bostom AG, et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med. 1995;332:286-291.
3. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med. 1997;337:230-236.
4. den Heijer M, Blom HJ, Gerrits WB, et al. Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? Lancet. 1995;345:882-885.
5. McCully KS. Homocysteine and vascular disease. Nat Med. 1996;2:386-389.
6. Refsum H, Uerland PM, Nygard O, et al. Homocysteine and cardiovascular disease. Annu Rev Med. 1998;49:31-62.
7. Harker LA, Ross R, Slichter SJ, et al. Homocysteine-induced atherosclerosis. The role of endothelial injury and platelet response in its genesis. J Clin Invest. 1976;58:731-741.
8. O.K. Lynn EG, Chung YH, et al. Homocysteine stimulates the production and secretion of cholesterol in hepatic cells. Biochim Biophys Acta. 1998; 1393:317-324.
9. Mosharov E, Granford MR, Banerjee R. The quantitatively important relationship between homocysteine metabolism and glutathione synthesis by the transsulfuration pathway and its regulation by redox changes. Biochemistry (Mosc). 2000;39:13005-13011.
10. Napoli C, D'Armiento FP, Mancini FP, et al. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia: intimal accumulation of low density lipoprotein and its oxidation precede monocyte recruitment into early atherosclerotic lesions. J Clin Invest. 1997;100:2680-2690.
11. Stary HC, Chandler AB, Glagow S, et al. A definition of initial, fatty streak, and intermediate lesions of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Atherosclerosis, American Heart Association. Circulation. 1994;89:2462-2478.
12. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993;362:801-809.
13. Ding Z, Xiong K, Issekutz TB. Regulation of chemokine-induced transendothelial migration of T-lymphocytes by endothelial activation: differential effects on naïve and memory T cells. J Leukoc Biol. 2000;67:825-833.
14. Holven KB, Aukrust P, Holm T, et al. Folic acid treatment reduces chemokine release from peripheral blood mononuclear cells in hyperhomocysteinemic subjects. Arterioscler Thromb Vasc Biol. 2002;22:699-703.
15. Duell PB, Malinow MR. Homocyst(e)ine, an important risk factor for atherosclerotic vascular disease. Curr Opin Lipidol. 1997;8:28-34.
16. Tucker LA, Seljaas GT, Hager RL. Body fat percentage of children varies according to their diet composition. J Am Diet Assoc. 1997;97:981-986.
17. Nguyen VT, Larson DE, Johnson RK, et al. Fat intake and adiposity in children of lean and obese parents. Am J Clin Nutr. 1996;63:507-513.
18. Gidding SS, Leibel RL, Daniels S, et al. Understanding obesity in youth: a statement of healthcare professionals from the Committee on Atherosclerosis and Hypertension in the Young of the Council on Cardiovascular Disease in the Young and the Nutrition Committee. American Heart Association Writing Group. Circulation. 1996;94:3383-3387.
19. Zwiauer KF, Pakosta R, Muller T, et al. Cardiovascular risk factors in obese children in relation to weight and body fat distribution. J Am Coll Nutr. 1992;11(suppl.):41S-50S.
20. Oshaung A, Bugge KH, Refsum H. Diet, an independent determinant for plasma total homocysteine: a cross sectional study of Norwegian workers on platforms in the North Sea. Eur J Clin Nutr. 1998;52:7-11.
21. Galli-Tsinopoulou A, Karamouzis M, Nousia-Arvanitakis S. Insulin resistance and hyperinsulinaemia in prepubertal obese children. J Pediatr Endocrinol Metab. 2003;16:555-560.
22. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc. 2000;5:369-380.
23. Gallistl S, Sudi K, Mangge H, et al. Insulin is an independent correlate of plasma homocysteine levels in obrse children and adolescents. Diabetes Care. 2000;23:1348-1352.
24. Wardlaw AJ, Walsh GM, Symon FA. Adhesion interactions involved in eosinophil migration through vascular endothelium. Annal NY Acad Sci. 1996;796:124-137.
25. Brown Z, Gerritsen ME, Carley WW, et al. Chemokine gene expression and secretion by cytokine-activated human microvascular endothelial cells. Differential regulation of monocyte chemoattractant protein-1 and interleukin-8 in response to interferon-γ. Am J Pathol. 1994;145:913-921.
26. Takeya M, Yoshimura T, Leonard EJ, et al. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an antimonocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol. 1993;24:534-539.
27. Altavilla D, Deodato B, Campo GM, et al. IRFI 04Z, a novel dual vitamin E-like antioxidant, inhibits activation of nuclear factor kappa B and reduces the inflammatory response in myocardial ischaemia-reperfusion injury. Cardiovasc Res. 2000;47:515-528.
28. Wang G, Siow YL, Karmin O. Homocysteine stimulates nuclear factor Kb activity and monocyte chemoattractant protein-1 expression in vascular smooth muscle cells: a possible role for protein kinase C. Biochem J. 2000;52:817-826.
29. Zhang HS, Cao EH, Qin JF. Intracellular redox status modulates monocyte chemoattractant protein-1 expression stimulated by homocysteine in endothelial cells. J Cardiovasc Pharmacol. 2003;42:258-265.
30. Zeng X, Dai J, Remick DG, et al. Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes. Circ Res. 2003;93:311-320.
31. Woo CW, Cheung F, Chan VW, et al. Homocysteine stimulated inducible nitric oxide synthase expression in macrophages: antagonizing effect of ginkgolides and bilobalide. Mol Cell Biochem. 2003;243:37-47.
32. Dasai A, Lankford HA, Warren JS. Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation. 2001;25:179-186.
33. Wang G, Siow YL. OK. Homocysteine induces monocyte chemoattractant protein-1 expression by activating NF-kappa B in THP-1 macrophages. Am J Physiol Heart Circ Physiol. 2001;280:H2840-H2847.
34. Wang G, Woo CW, Sung FL, et al. Increased monocyte adhesion to aortic endothelium in rats with homocysteinemia: role of chemokine and adhesion molecules. Arterioscler Thromb Vasc Biol. 2002;22:1777-1783.